{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:51:24Z","timestamp":1774623084667,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100013262","name":"State Key Laboratory of Respiratory Disease","doi-asserted-by":"crossref","award":["SKLRD-QN-201710"],"award-info":[{"award-number":["SKLRD-QN-201710"]}],"id":[{"id":"10.13039\/100013262","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2018A030313107"],"award-info":[{"award-number":["2018A030313107"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangzhou Institute of Respiratory Health","award":["2019GIRHZ04"],"award-info":[{"award-number":["2019GIRHZ04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cytomegalovirus (CMV) infection is a leading cause of morbidity and mortality after transplantation. This study aimed to investigate CMV seroprevalence, infection, and disease in Chinese thoracic organ transplant recipients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The clinical data of the patients who underwent lung and\/or heart transplantation between January 2015 and October 2020 were retrospectively collected from four transplantation centers in China.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 308 patients were analyzed. The CMV serostatus was donor positive (D<jats:sup>+<\/jats:sup>) recipient negative (R<jats:sup>\u2212<\/jats:sup>) in 19 (6.17%) patients, D<jats:sup>+<\/jats:sup>\/R<jats:sup>+<\/jats:sup> in 233 (75.65%), D<jats:sup>\u2212<\/jats:sup>\/R<jats:sup>+<\/jats:sup> in 36 (11.69%), and D<jats:sup>\u2212<\/jats:sup>\/R<jats:sup>\u2212<\/jats:sup>  in 20\u00a0(6.50%). CMV DNAemia was detected in 52.3% of the patients and tissue-invasive CMV disease was diagnosed in 16.2% of the patients. Only 31.8% of the patients adhered to the postdischarge valganciclovir therapy. The D<jats:sup>+<\/jats:sup>\/R<jats:sup>\u2212<\/jats:sup> serostatus (odds ratio [OR]: 18.32; 95% confidence interval [CI]:1.80-188.68), no valganciclovir prophylaxis (OR: 2.64; 95% CI: 1.05\u20136.64), and higher doses of rabbit anti-human thymocyte globulin (&gt;\u20092\u2009mg\/kg) (OR: 4.25; 95% CI: 1.92\u20139.42) were risk factors of CMV disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>CMV seroprevalence was high in Chinese thoracic organ transplant donors and recipients. The low adherence rate to the postdischarge CMV prophylaxis therapy in Chinese patients is still an unresolved issue.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07853-x","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T05:13:11Z","timestamp":1669180391000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cytomegalovirus seroprevalence, infection, and disease in Chinese thoracic organ transplant recipients: a retrospective cohort study"],"prefix":"10.1186","volume":"22","author":[{"given":"Chunrong","family":"Ju","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaobo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingdong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanli","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaoyan","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danxia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongchang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxing","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"issue":"10","key":"7853_CR1","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.healun.2019.08.004","volume":"38","author":"KK Khush","year":"2019","unstructured":"Khush KK, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult heart transplantation report\u20142019; focus theme: donor and recipient size match. J Heart Lung Transplant. 2019;38(10):1056\u201366.","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"7853_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ccc.2018.08.010","volume":"35","author":"M Alsaeed","year":"2019","unstructured":"Alsaeed M, Husain S. Infections in heart and lung transplant recipients. Crit Care Clin. 2019;35(1):75\u201393.","journal-title":"Crit Care Clin"},{"issue":"8","key":"7853_CR3","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.healun.2015.03.015","volume":"34","author":"JF Delgado","year":"2015","unstructured":"Delgado JF, et al. Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation. J Heart Lung Transplant. 2015;34(8):1112\u20139.","journal-title":"J Heart Lung Transplant"},{"issue":"24","key":"7853_CR4","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1001\/jama.1989.03420240121038","volume":"261","author":"RH Rubin","year":"1989","unstructured":"Rubin RH. The indirect effects of cytomegalovirus infection on the outcome of organ transplantation. JAMA. 1989;261(24):3607\u20139.","journal-title":"JAMA"},{"issue":"8","key":"7853_CR5","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/j.1600-6143.2004.00505.x","volume":"4","author":"MR Zamora","year":"2004","unstructured":"Zamora MR. Cytomegalovirus and lung transplantation. Am J Transplant. 2004;4(8):1219\u201326.","journal-title":"Am J Transplant"},{"issue":"6","key":"7853_CR6","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/TP.0000000000002191","volume":"102","author":"CN Kotton","year":"2018","unstructured":"Kotton CN, et al. The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2018;102(6):900\u201331.","journal-title":"Transplantation"},{"issue":"23","key":"7853_CR7","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1097\/CM9.0000000000000543","volume":"132","author":"CX Hu","year":"2019","unstructured":"Hu CX, et al. Lung transplantation in China between 2015 and 2018. Chin Med J (Engl). 2019;132(23):2783\u20139.","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"7853_CR8","doi-asserted-by":"publisher","first-page":"220","DOI":"10.5935\/0103-507X.20160049","volume":"28","author":"GA Westphal","year":"2016","unstructured":"Westphal GA, et al. Guidelines for the assessment and acceptance of potential brain-dead organ donors. Revista Brasileira de terapia intensiva. 2016;28(3):220\u201355.","journal-title":"Revista Brasileira de terapia intensiva"},{"issue":"11","key":"7853_CR9","doi-asserted-by":"publisher","first-page":"ofz480","DOI":"10.1093\/ofid\/ofz480","volume":"6","author":"S Boonsathorn","year":"2019","unstructured":"Boonsathorn S, et al. Analysis of ganciclovir-resistant cytomegalovirus infection caused by the UL97 Gene mutation in codons 460 and 520 in pediatric patients: a case series. Open Forum Infect Dis. 2019;6(11):ofz480.","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"7853_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/cid\/ciw668","volume":"64","author":"P Ljungman","year":"2017","unstructured":"Ljungman P, et al. Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials. Clin Infect Dis. 2017;64(1):87\u201391.","journal-title":"Clin Infect Dis"},{"key":"7853_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ajo.2021.03.051","volume":"228","author":"Standardization of Uveitis Nomenclature SUN Working Group","year":"2021","unstructured":"Standardization of Uveitis Nomenclature SUN Working Group. Classification criteria for cytomegalovirus retinitis. Am J Ophthalmol. 2021;228:245\u201354.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"7853_CR12","first-page":"1182","volume":"29","author":"Q Wei","year":"2009","unstructured":"Wei Q, et al. Multivariate analysis of the risk factors of cytomegalovirus pneumonia after renal transplantation. Nan Fang Yi Ke Da Xue Xue Bao. 2009;29(6):1182\u20134.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"5","key":"7853_CR13","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.transproceed.2004.04.079","volume":"36","author":"G Lianghui","year":"2004","unstructured":"Lianghui G, et al. Deferred versus prophylactic therapy with gancyclovir for cytomegalovirus in allograft liver transplantation. Transpl Proc. 2004;36(5):1502\u20135.","journal-title":"Transpl Proc"},{"issue":"3","key":"7853_CR14","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1002\/rmv.2034","volume":"29","author":"M Zuhair","year":"2019","unstructured":"Zuhair M, et al. Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis. Rev Med Virol. 2019;29(3):2034.","journal-title":"Rev Med Virol"},{"issue":"1","key":"7853_CR15","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1186\/s12879-019-4607-x","volume":"19","author":"Y La","year":"2019","unstructured":"La Y, et al. Human cytomegalovirus seroprevalence and titres in solid organ transplant recipients and transplant donors in Seoul, South Korea. BMC Infect Dis. 2019;19(1):948.","journal-title":"BMC Infect Dis"},{"issue":"11","key":"7853_CR16","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1086\/652438","volume":"50","author":"SL Bate","year":"2010","unstructured":"Bate SL, Dollard SC, Cannon MJ. Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988\u20132004. Clin Infect Dis. 2010;50(11):1439\u201347.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"7853_CR17","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1128\/JCM.01173-06","volume":"45","author":"CC Bauer","year":"2007","unstructured":"Bauer CC, et al. Relationship between cytomegalovirus DNA load in epithelial lining fluid and plasma of lung transplant recipients and analysis of coinfection with Epstein-Barr virus and human herpesvirus 6 in the lung compartment. J Clin Microbiol. 2007;45(2):324\u20138.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"7853_CR18","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1378\/chest.118.6.1653","volume":"118","author":"GC Riise","year":"2000","unstructured":"Riise GC, et al. Quantification of cytomegalovirus DNA in BAL fluid: a longitudinal study in lung transplant recipients. Chest. 2000;118(6):1653\u201360.","journal-title":"Chest"},{"issue":"6","key":"7853_CR19","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1086\/422327","volume":"190","author":"GP Westall","year":"2004","unstructured":"Westall GP, et al. Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: a longitudinal study of lung transplant recipients. J Infect Dis. 2004;190(6):1076\u201383.","journal-title":"J Infect Dis"},{"issue":"5","key":"7853_CR20","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.healun.2008.02.002","volume":"27","author":"S Gupta","year":"2008","unstructured":"Gupta S, et al. High incidence of cytomegalovirus disease in D+\/R- heart transplant recipients shortly after completion of 3\u2009months of valganciclovir prophylaxis. J Heart Lung Transplant. 2008;27(5):536\u20139.","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"7853_CR21","doi-asserted-by":"publisher","first-page":"e13094","DOI":"10.1111\/tid.13094","volume":"21","author":"D Kabbani","year":"2019","unstructured":"Kabbani D, et al. High incidence of clinically significant cytomegalovirus infection in CMV D+\/R\u2009+\u2009lung transplant recipients receiving 3\u2009months of antiviral prophylaxis. Transpl Infect Dis. 2019;21(4):e13094.","journal-title":"Transpl Infect Dis"},{"issue":"5","key":"7853_CR22","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.jinf.2015.06.013","volume":"71","author":"R San-Juan","year":"2015","unstructured":"San-Juan R, et al. Effect of delaying prophylaxis against CMV in D+\/R- solid organ transplant recipients in the development of CMV-specific cellular immunity and occurrence of late CMV disease. J Infect. 2015;71(5):561\u201370.","journal-title":"J Infect"},{"issue":"2","key":"7853_CR23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/tid.12036","volume":"15","author":"SP Hammond","year":"2013","unstructured":"Hammond SP, et al. Cytomegalovirus disease in lung transplantation: impact of recipient seropositivity and duration of antiviral prophylaxis. Transpl Infect Dis. 2013;15(2):163\u201370.","journal-title":"Transpl Infect Dis"},{"key":"7853_CR24","doi-asserted-by":"publisher","first-page":"175346661987855","DOI":"10.1177\/1753466619878555","volume":"13","author":"P Solidoro","year":"2019","unstructured":"Solidoro P, et al. Tailored combined cytomegalovirus management in lung transplantation: a retrospective analysis. Ther Adv Respir Dis. 2019;13:1753466619878555.","journal-title":"Ther Adv Respir Dis"},{"issue":"9","key":"7853_CR25","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1111\/j.1600-6143.2012.04087.x","volume":"12","author":"SF Atabani","year":"2012","unstructured":"Atabani SF, et al. Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy. Am J Transplant. 2012;12(9):2457\u201364.","journal-title":"Am J Transplant"},{"key":"7853_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66553-1","author":"EM Hodson","year":"2013","unstructured":"Hodson EM, et al. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev. 2013. https:\/\/doi.org\/10.1016\/S0140-6736(05)66553-1.","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"7853_CR27","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7326\/0003-4819-152-12-201006150-00003","volume":"152","author":"SM Palmer","year":"2010","unstructured":"Palmer SM, et al. Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial. Ann Intern Med. 2010;152(12):761\u20139.","journal-title":"Ann Intern Med"},{"key":"7853_CR28","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.12688\/f1000research.16321.1","volume":"7","author":"MN Chitasombat","year":"2018","unstructured":"Chitasombat MN, Watcharananan SP. Burden of cytomegalovirus reactivation post kidney transplant with antithymocyte globulin use in Thailand: a retrospective cohort study. F1000Res. 2018;7:1568.","journal-title":"F1000Res"},{"issue":"5","key":"7853_CR29","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/infdis\/jiz194","volume":"220","author":"H Kaminski","year":"2019","unstructured":"Kaminski H, et al. Different impact of rATG induction on CMV infection risk in D\u2009+\u2009R- and R\u2009+\u2009KTRs. J Infect Dis. 2019;220(5):761\u201371.","journal-title":"J Infect Dis"},{"issue":"2","key":"7853_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1399-3062.2004.00054.x","volume":"6","author":"KS Ozaki","year":"2004","unstructured":"Ozaki KS, et al. Sequential cytomegalovirus antigenemia monitoring in kidney transplant patients treated with antilymphocyte antibodies. Transpl Infect Dis. 2004;6(2):63\u20138.","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"7853_CR31","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.transproceed.2008.12.028","volume":"41","author":"F Clinckart","year":"2009","unstructured":"Clinckart F, et al. Basiliximab as an alternative to antithymocyte globulin for early immunosuppression in lung transplantation. Transpl Proc. 2009;41(2):607\u20139.","journal-title":"Transpl Proc"},{"issue":"6","key":"7853_CR32","first-page":"1135","volume":"125","author":"W Wang","year":"2012","unstructured":"Wang W, et al. A retrospective comparison of the efficacy and safety in kidney transplant recipients with basiliximab and anti-thymocyte globulin. Chin Med J (Engl). 2012;125(6):1135\u201340.","journal-title":"Chin Med J (Engl)"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07853-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07853-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07853-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T05:14:05Z","timestamp":1669180445000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07853-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["7853"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07853-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,22]]},"assertion":[{"value":"13 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of the First Affiliated Hospital of Guangzhou Medical University (approval number: 2021\u2009K-01), which also granted administrative permission to access the clinical data used in the study. Informed consent was waived by this committee due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"872"}}